Home NDC 43063-474-30 ATORVASTATIN CALCIUM
Product NDC 43063-474
Requested package NDC 43063-474-30
11-digit product format 430630474
Labeler code 43063
Product ID 43063-474_5c2bb6c2-4bb4-c845-e063-6294a90ac675
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ATORVASTATIN CALCIUM
Dosage form TABLET, FILM COATED
Route ORAL
Labeler PD-Rx Pharmaceuticals, Inc.
Application ANDA090548
Marketing category ANDA
Marketing start 2012-05-29
Substance ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE
Active strength 10 mg/1
Pharmacologic classes HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090548-001 ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 A090548-002 ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 A090548-003 ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 A090548-004 ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 c2088c7a36db…2026-09-14 22:38:34 2026-08 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090548-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-05-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090548-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-05-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090548-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-05-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090548-004 ATORVASTATIN CALCIUM EQ 80MG BASE TABLET / ORAL AB 2012-05-29 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 180 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base ATORVASTATIN CALCIUM
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE 10 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination YRZ789OWMI Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 617312 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 43063-474-30 ATORVASTATIN CALCIUM 30 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 30 32
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE ACTIVE INGREDIENT YRZ789OWMI ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 ATORVASTATIN ACTIVE MOIETY A0JWA85V8F ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 CALCIUM ACETATE INACTIVE INGREDIENT Y882YXF34X ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 POLYETHYLENE GLYCOL 8000 INACTIVE INGREDIENT Q662QK8M3B ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 SODIUM CARBONATE INACTIVE INGREDIENT 45P3261C7T ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 12
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 43063-474 ATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 30 Current NDC, Legacy NDC, 1 package rows 20250303_09c6c750-ae05-459f-83e8-4a9e4fd85212.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 3 of 3 · 45 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 43063-474-30 43063047430 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-474-30) 2012-05-29 0000-00-00 No No Current